Figure S4 from ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies

Francesca Zammarchi,Karin E. Havenith,Nikoleta Sachini,Narinder Janghra,Simon Chivers, Esohe Idusogie,Eugenio Gaudio,Chiara Tarantelli,Francois Bertelli, Kathleen Santos,Peter Tyrer,Simon Corbett,Filippo Spriano,Gaetanina Golino,Luciano Cascione,Francesco Bertoni,John A. Hartley,Patrick H. van Berkel

crossref（2024）

引用 0|浏览4

暂无评分

摘要

Supplementary Fig. S4. Time course of DNA ICL formation in KARPAS-299 cells following a 2-hour treatment with ADCT-602 or SG3199. Results are presented as a mean percentage decrease in OTM ± SD (n = 4). ICL interstrand crosslinking; OTM Olive tail moment.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要